Building the future of genetic medicine in Columbus, Ohio

Sarepta Therapeutics, a global biotechnology company engineering precision medicine solutions for rare diseases, is building a significant R&D operation in the emerging life science hub of Columbus, Ohio. Home to powerhouse research centers at The Ohio State University and Nationwide Children’s Hospital (#6 ranked pediatric center in the U.S., according to US News & World Report), Columbus has attracted significant industry investment from the likes of Amgen, Andelyn Biosciences, Forge Biologics, and STAQ Pharma.